A phase II study of biweekly pralatrexate and docetaxel in patients with advanced esophageal and gastroesophageal carcinoma that have failed first-line platinum-based therapy

Brian Petullo, Lai Wei, Melissa Yereb, Alison Neal, Jeffrey Rose, Tanios Bekaii-Saab, Christina Wu

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of biweekly pralatrexate and docetaxel in patients with advanced esophageal and gastroesophageal carcinoma that have failed first-line platinum-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences